HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling

Burkitt lymphoma (BL) is an aggressive B-cell neoplasm that is currently treated by intensive chemotherapy in combination with anti-CD20 antibodies. Because of their toxicity, current treatment regimens are often not suitable for elderly patients or for patients in developing countries where BL is e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Walter, Roland, Pan, Kuan-Ting, Doebele, Carmen, Comoglio, Federico, Tomska, Katarzyna, Bohnenberger, Hanibal, Young, Ryan M., Jacobs, Laura, Keller, Ulrich, Bönig, Halvard, Engelke, Michael, Rosenwald, Andreas, Urlaub, Henning, Staudt, Louis M., Serve, Hubert, Zenz, Thorsten, Oellerich, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290984/
https://ncbi.nlm.nih.gov/pubmed/28064214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-06-721423
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados